Steven M. Dubinett spends much of his time researching Immunology, Cancer research, Immune system, Lung cancer and Cytokine. Steven M. Dubinett has included themes like Cancer and Lung in his Immunology study. His Cancer research study combines topics from a wide range of disciplines, such as Autocrine signalling, Internal medicine, Signal transduction, Growth factor receptor and Interleukin 12.
His studies in Immune system integrate themes in fields like Prostaglandin E2, Cell, Receptor and Antigen. The Lung cancer study combines topics in areas such as Angiogenesis, Carcinogenesis, Apoptosis, Sense and Adenocarcinoma. His Cytokine research incorporates elements of Tumor necrosis factor alpha and Adoptive cell transfer.
The scientist’s investigation covers issues in Cancer research, Lung cancer, Immunology, Cancer and Internal medicine. His study on Cancer research also encompasses disciplines like
His study in Cancer is interdisciplinary in nature, drawing from both microRNA and Disease. His Internal medicine research is multidisciplinary, relying on both Endocrinology and Oncology. His Immune system research is multidisciplinary, incorporating perspectives in Cytotoxic T cell, Myeloid-derived Suppressor Cell and Antigen.
Steven M. Dubinett focuses on Cancer research, Lung cancer, Cancer, Immune system and Immunotherapy. His biological study focuses on Tumor microenvironment. His biological study spans a wide range of topics, including T cell and Antigen-presenting cell.
Steven M. Dubinett has researched Lung cancer in several fields, including Inflammation, Tumor progression, Lung and Adenocarcinoma. His Cancer study deals with Oncology intersecting with Cancer immunotherapy and Progression-free survival. The study incorporates disciplines such as Immunofluorescence, Cell cycle, Myeloid-derived Suppressor Cell and Antigen in addition to Immune system.
His main research concerns Cancer research, Lung cancer, Lung, Cancer and Carcinogenesis. His Cancer research research includes elements of Cell, Inflammation, Immune system, Gene silencing and Epigenetics. His Inflammation research integrates issues from Interleukin, Cytokine and Angiogenesis.
The concepts of his Lung cancer study are interwoven with issues in Tumor microenvironment, Carcinoma and Adenocarcinoma. His Cancer research is multidisciplinary, relying on both Preclinical imaging, Oxidative phosphorylation, Membrane potential and Cell growth. His studies deal with areas such as Immunohistochemistry, Positron emission tomography, Targeted therapy and Survival analysis as well as Carcinogenesis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Prostaglandin E2 Induces FOXP3 Gene Expression and T Regulatory Cell Function in Human CD4+ T Cells
Felicita Baratelli;Ying Lin;Li Zhu;Seok-Chul Yang.
Journal of Immunology (2005)
Specific Inhibition of Cyclooxygenase 2 Restores Antitumor Reactivity by Altering the Balance of IL-10 and IL-12 Synthesis
Marina Stolina;Sherven Sharma;Ying Lin;Mariam Dohadwala.
Journal of Immunology (2000)
Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: up-regulation of interleukin 10 and down-regulation of interleukin 12 production.
Min Huang;Marina Stolina;Sherven Sharma;Jenny T. Mao.
Cancer Research (1998)
Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma.
Paulo C Rodriguez;Claudia P. Hernandez;David G. Quiceno;Steven M Dubinett.
Journal of Experimental Medicine (2005)
Tumor Cyclooxygenase-2/Prostaglandin E2–Dependent Promotion of FOXP3 Expression and CD4+CD25+ T Regulatory Cell Activities in Lung Cancer
Sherven Sharma;Seok-Chul Yang;Li Zhu;Karen Reckamp.
Cancer Research (2005)
IL-10 production in cutaneous basal and squamous cell carcinomas. A mechanism for evading the local T cell immune response.
J Kim;R L Modlin;R L Moy;S M Dubinett.
Journal of Immunology (1995)
A comparison of gene transfer methods in human dendritic cells
J F Arthur;L H Butterfield;M D Roth;L A Bui.
Cancer Gene Therapy (1997)
Human non-small cell lung cancer cells express a type 2 cytokine pattern
Min Huang;Jianyi Wang;Paul Lee;Sherven Sharma.
Cancer Research (1995)
Cancer and inflammation: Promise for biologic therapy
Sandra Demaria;Eli Pikarsky;Michael Karin;Lisa M. Coussens.
Journal of Immunotherapy (2010)
Cyclooxygenase-2–Dependent Regulation of E-Cadherin: Prostaglandin E2 Induces Transcriptional Repressors ZEB1 and Snail in Non–Small Cell Lung Cancer
Mariam Dohadwala;Seok-Chul Yang;Jie Luo;Sherven Sharma.
Cancer Research (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: